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Background: Epidemic diphtheria is still poorly understood and continues to challenge both developing and
developed countries. In the backdrop of poor immunization coverage, non-existent adult boosters, weak case based
surveillance and persistence of multiple foci, there is a heightened risk of re-emergence of the disease in epidemic
forms in India. Investigating each outbreak to understand the epidemiology of the disease and its current status in
the country is therefore necessary. Dhule a predominantly tribal and rural district in Northern Maharashtra has
consistently recorded low vaccination coverages alongside sporaidic cases of diphtheria over the last years.
Methods: This study reports the findings of an onsite survey conducted to assess a recent outbreak of diphtheria in
Dhule district and the response mounted to it. Secondary data regarding outbreak detection and response were
obtained from the district surveillance office. Clinical data were extracted from hospital records of eleven lab
confirmed cases including one death case. Frequency distributions were calculated for each identified clinical and
non- clinical variable using Microsoft™ ExcelW 2010.
Results: Our findings suggest a shift in the median age of disease to adolescents (10-15 years) without gender
differences. Two cases (18%) reported disease despite immunization. Clinical symptoms included cough (82%), fever
(73%), and throat congestion (64%). About 64% and 36% of the 11 confirmed cases presented with a well defined
pseudomembrane and a tonsillar patch respectively. Drug resistance was observed in all three culture positive
cases. One death occurred despite the administration of Anti-Diphtheric Serum in a partially immunized case
(CFR 9%). Genotyping and toxigenicity of strain was not possible due to specimen contamination during transport
as testing facilities were unavailable in the district.
Conclusions: The outbreak raises several concerns regarding the epidemiology of diphtheria in Dhule. The reason
for shift in the median age despite consistently poor immunization coverage (below 50%) remains unclear.
Concomitant efforts should now focus on improving and monitoring primary immunization and booster coverages
across all age groups. Gradually introducing adult immunization at ten year intervals may become necessary to
prevent future vulnerabilities. Laboratory networks for genotyping and toxigenicity testing are urgently mandated at
district level given the endemicity of the disease in the surrounding region and its recent introduction in remote
Dhule. Contingency funds with pre- agreements to obtain ADS and DT/Td vaccines at short notice and developing
standard case management protocols at district level are necessary. Monitoring the disease, emerging strains and
mutations, alongside drug resistance through robust and effective surveillance is a pragmatic way forward.
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Diphtheria is endemic in most developing countries in-
cluding India. It is transmitted through aerosols and is
communicable for two to six weeks in the absence of
antibiotic treatment [1-4]. The incubation period is two
to five days, however symptoms may develop up to ten
days after exposure. Cyclic epidemics of diphtheria have
been documented since the 16th century in both devel-
oped and developing countries. The most striking resur-
gence was witnessed in the nineties in Eastern Europe
[5]. The main reasons for the re-emergence of diph-
theria in the post vaccine era are waning of immunity
with age and improved immunization rates in chil-
dren which reduces circulating wild organisms and
hence the opportunities for natural boosting through
subclinical infections [6].
As a result, a shift in the median age of incidence to
adolescents and adults has been reported from several
countries [6-8]. Furthermore, cases and deaths have been
documented in previously immunized individuals [9].
Epidemic diphtheria is still poorly understood and im-
munization to date remains mainstay for prevention.
There is no standard vaccination schedule for diphtheria,
although all schedules deliver a primary series consisting
of three doses starting at a minimum age of six weeks
with a minimum interval of four weeks between the doses.
Choice for the timing and number of boosters depends
mainly on other diseases in the combination vaccines used
in the respective Expanded Program for Immunization
(EPI) programs and on the sero-epidemiology and ende-
micity of the disease in each country [10].
India accounted for over 71% of the 4880 diphtheria
cases in the world in 2011 [11]. Although this is partly
accounted for by disproportionate size of the Indian
birth cohort and influenced by variable reporting effi-
ciency of diphtheria cases between countries, the disease
remains largely neglected and widely prevalent with
periodic intermittent outbreaks in over 12 states of the
country [1-4,9,12-24]. Given the persistence of multiple
foci in all regions of the country there is indeed a height-
ened risk of re-emergence of the disease in epidemic
forms. An improved understanding of the nature of each
outbreak is therefore mandated to generate a pool of evi-
dence regarding the current disease status in India. This
paper aims to further existing knowledge about diph-
theria in the Western state of Maharashtra.
We report an assessment of the August 2011 out-
break in Pashte village in rural tribal Dhule district, of
Northern Maharashtra and the response mounted to it.
Cases have been earlier reported from the region espe-
cially Malegaon block of neighbouring Nashik district
[9]. However, this is the first time a geographically local-
ized outbreak of significant size is reported from Dhule
district. The main objective the study was to describethe nature of the disease itself and the outbreak in the
region, identify the probable causes for persistence of
the disease in the area and to highlight some strategies
to prevent its recurrence. The paper aims to highlight
the importance of the Integrated Disease Surveillance
System/ Project (IDSP) in monitoring disease epidemi-
ology and in detecting and responding to outbreaks in a
structured and timely manner.
Methods
Study area
Pashte village lies in Sindhkhede block of Dhule district
and covers a population of 3359. The Primary Health
Care Center (PHC) Betawad serves a population of
34,492 including Pashte and is a reporting unit within
the IDSP. It is manned by two Medical Officers, 11 para-
medical staff at the headquarters and five satellite sub-
centers. The subcenter in Pashte is manned by one
Auxiliary Nurse and Midwife. Dhule is one of the 34 dis-
tricts in Maharashtra which implements the Integrated
Disease Surveillance Project (IDSP) since 2005. The sys-
tem uses syndromic, presumptive and lab confirmation
approaches to collect data on cases of 21 priority dis-
eases and syndromes through S, P and L reporting for-
mats respectively from identified public and private
reporting units on a weekly basis from both urban and
rural areas including diphtheria [25]. The main objective
of the system is outbreak detection and response. Every
district has a Rapid Response Team which is activated as
soon as an action threshold for a disease is reached
which is a single confirmed case for diphtheria.
GIS mapping
The location of households of the cases; the primary
school; and the sub-center were identified and GPS co-
ordinates were collected using a handheld e-Trex GPS
machine after calibration. Location was collected in de-
gree decimal (hddd.ddddd). The North reference was
kept true. A point layer was generated using the GPS co-
ordinates and was validated by overlaying the points on
Google Earth which were then overlaid on the Pashte
boundary map using ArcGIS version 9.3 to generate
maps (Figure 1).
Case definitions
We classified cases as per the WHO recommendations
[26]. A probable case was defined as a person having
laryngitis or pharyngitis or tonsillitis, and an adherent
membrane / patch of the tonsils, pharynx and/or nose.
Confirmed case was defined as a probable case with lab
confirmation (isolation of corynebacterium diphtheriae
from a clinical specimen) as smear and/ or culture
positive.
Figure 1 Spot map.
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Secondary data regarding outbreak detection, investigation
and response was collected from the Integrated Disease
Surveillance (IDSP) office in Dhule district. Clinical data
on identified treatment and outcome variables were ex-
tracted from hospital charts and discharge case reports of
11 lab confirmed cases by a consultant physician in gen-
eral medicine (nine cases including the death case treated
at the medical teaching (civil) hospital in Dhule and two
cases treated at the Kasturba Hospital for Infectious
Diseases, Mumbai). The data were entered, cleaned and
analyzed in Microsoft™ ExcelW 2010. Frequency distribu-
tions showing number and percentages were generated
for each identified clinical and non-clinical variables
Ethics approval
The study was a part of the doctoral dissertation of the
lead author and was passed through the Ethical Com-
mittee of the Medical Faculty, University of Heidelberg,
Germany (Approval Number: S381/2010) and by the
University of Delhi, India (Approval Number: Anth/
2009/585). Additionally relevant permissions and consents
were obtained from the District Health Officer (DHO),
the Gram Panchayat (village administration) members and
the village leaders. Informed verbal consent was obtained
from all individuals from whom swabs were collected.
Results
Timeline of outbreak
A six year male child presented at medical teaching hos-
pital, Dhule with one day history of fever, cough, sorethroat, difficulty in swallowing and breathing, congestion
in throat and swelling in neck (bull’s neck) along with a
well formed pseudo-membrane with pre-admission con-
sultation with an Ear Nose Throat (ENT) consultant on
July 28, 2011. Diagnosis was confirmed by clinical exam-
ination and a positive smear and culture. Anti Diphthe-
ria Serum (ADS) was administered single dose 80,000 IU
intravenously over six hours immediately along with
6.6 LIU crystalline penicillin six hourly. The condition
worsened despite ADS and the patient passed away on
August 2, 2011- five days post admission. Death was in-
formed to District Health Officer (DHO) and District
Surveillance Officer (DSO) under the IDSP which imme-
diately triggered actions at district, block and village
levels. The district Rapid Response Team (RRT) was ac-
tivated and house to house surveys were conducted for
two weeks and over 560 school children (0–6 years)
were screened. No clinically probable cases were identi-
fied. Mass prophylaxis with Azithromycin (10 mg/kg)
dose adjusted to age and weight was administered to all
fever cases.
A second wave started six weeks later with the diagno-
sis of a six year old male (cousin of the index death case)
on September 19, 2011, reported over telephone to IDSP,
triggering a second phase of control measures. Surveys
were conducted in 633 households and the primary and
secondary schools. A short questionnaire was designed
and all concerned health staff from the PHC and sub-
centers were trained in screening and data collection for
the house to house survey and a medical camp. All
households in the village were covered by three teams
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were screened. Clinically confirmed cases and their con-
tacts were continuously tracked. Additionally other health
conditions were attended to during the survey and at-
tempts were made to obtain verbal vaccination history or
cards during the visits. Respiratory etiquette, hand hygiene
was advocated. Ninety one cases with history of sore
throat (29.6%); fever (66.0%); running nose (63.7%); or
pain on swallowing (44%) were identified during the house
to house visits by paramedical staff and referred to the
subcenter for further clinical examination.
An onsite medical camp was conducted by the district
IDSP Rapid Response Team (RRT) that included a pae-
diatrician, microbiologist, two lab technicians, ENT con-
sultant, epidemiologist and a public health specialist
from the medical teaching hospital. On arrival 85 throat
swabs were obtained for bacterial culture as microbiolo-
gist and lab technicians were available on-site and in
order to avoid individual travel to the district hospital
which is 45kms away. The team also took a broad all
inclusive approach to treatment by administering
Azithromycin (10 mg/kg) dose adjusted to age, and
weight for seven days. Further, detailed examination by
paediatricians and internists identified ten probable
cases that met clinical suspicion with either a tonsillar
patch or a well-defined membrane and were isolated for
hospital admission.
Bacteriology
Samples were collected and transported in sterile test
tubes by qualified technicians and microbiologists from
the Government medical teaching hospital laboratory.
Staining techniques included Gram’s staining followed
by Albert’s staining. Culture techniques included ino-
culation using streaking on blood agar medium and
blood potassium tellurite agar was used as the selective
medium. Antimicrobial susceptibility was tested using
Kirby-Bauer (disc diffusion method) with American
Type Culture Collection (ATCC) strains of gram positive
and gram negative organisms as controls. All ten prob-
able cases were lab confirmed. The results were positive
for C. Diphtheriae in nine smears and two cultures. OneTable 1 Age and sex wise attack rates of confirmed cases
Age
group
Males
(n)
Confirmed
cases
Attack
Rate (%)
Females
(n)
Confi
cas
0 – 5 179 1 0.6 173 1
6 – 10 111 1 0.9 106 1
10 – 15 141 4 2.8 129 3
15 – 45 796 0 0 723 0
45 and above 514 0 0 487 0
Total 1741 6 0.3 1618 5case was smear negative but culture positive. Including
the death case (which was both smear and culture posi-
tive) we report results of 11 lab confirmed cases in our
study. Samples were sent for bio-typing and toxigenicity
testing to the referral lab under IDSP in Pune, but were
contaminated and hence unfit for processing. All three
culture positive samples were found resistant to penicil-
lin, ampicillin, cefuroxime, and ciprofloxacin.
Age and gender distribution
Six of 11 (54.5%) lab confirmed cases (including the death
case) were males and five were females (45.5%). Attack
rates increased with age and were highest for the age
group 10–15 years. Gender distribution remained similar
across age groups (Table 1). The median age of the ten
smear positive cases was 11 years (range 5–15 years) and
that of the three culture positive cases was 12 years (range
6–13 years).
Vaccination status
Attempts made to obtain vaccination coverage estimates
for the village through registers at the PHC, vaccination
diaries of subcenter and PHC staff and the National
Rural Health Mission (NRHM) Reproductive and Child
Health II (RCH II) databases were in vain due to incom-
plete documentation and monitoring of targets instead
of actual number of children vaccinated. Secondly, pa-
rental recall and vaccination cards were sought during
two separate visits but were also unsuccessful. Nonethe-
less, primary immunization status was confirmed in two
of the ten (20%) survivors- one verbally and one sup-
ported by a vaccination card). Reports of the death case
showed that DPT1 and DTP2 were administered in pri-
vate facility and records for DPT3 and 1st booster were
recovered from the PHC confirming that the child was
at least partially immunized.
Pre-admission consultation and duration of
hospitalization
Over 45.4% cases admitted having consulted private pra-
ctitioner for a second opinion (mostly with ENT con-
sultants and one with an ayurvedic practitioner) beforermed
es
Attack
Rate (%)
Total
population (N)
Total
Confirmed cases
Attack
rate (%)
0.6 352 2 0.6
0.9 217 2 0.9
2.3 270 7 2.6
0 1519 0 0
0 1001 0 0
0.3 3359 11 0.3
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ration for hospitalization ranged from 1–15 days and
maximum (54.5%) cases were hospitalized for six days.
Clinical symptoms and treatment outcomes
Cough (82%), low grade fever (73%), and throat con-
gestion (64%) were the most frequently reported clinical
symptoms (Figure 2). The death case presented with
high grade fever. Over 90% of the cases were faucial or
tonsillar type and 64% and 36% cases presented with
a well formed pseudomembrane and a tonsillar patch
respectively. Two cases presented with classical neck
swelling (bull’s neck). Only one case progressed to re-
spiratory complications and died (CFR 9%). Neuro-
logical or cardiac complications did not occur in any
of the cases.
Treatment
ADS was administered to all patients immediately on ad-
mission. The ADS dose used for treatment ranged from
40,000 IU to 100,000 IU according to severity of disease
and was administered intravenously in a single dose over
four to six hours. Three children developed mild reac-
tions that included vomiting and puffiness of eyes. ADS
was stopped in one child after four test doses. Mono-
therapy with crystalline penicillin (12,500-25,000 IU/kg)
and in cases of resistance or intolerance Azithromycin
(10 mg/kg) was included in the regimen. The duration
of antibiotic therapy was ten days in seven cases and
seven days in two surviving cases. One case (documented
history of primary immunization) was treated with IV an-
tibiotics for 14 days. Only two cases were vaccinatedFigure 2 Frequency of reported clinical symptoms.before discharge due to unavailability of the DT vaccine.
Chemoprophylaxis with Azithromycin (10 mg/kg body
weight) was administered to all contact cases for three to
ten days.
Discussion
The outbreak provides a realistic description of how the
district authorities detected and reacted to the event. Al-
though the first response mounted was fairly reasonable
the incident raises several concerns regarding the epi-
demiology of diphtheria itself in the district as well as
the preparedness of the primary healthcare system. A re-
markable feature of this outbreak was recognition of the
risk of re-emergence of diphtheria by the district author-
ities and moreover their proactive initiative to investigate
the problem and to plug gaps. Part of the credit goes to
the Integrated Disease Surveillance System which cur-
rently being the only significant large scale surveillance
effort in the state is paramount in raising awareness re-
garding surveillance of emerging and re-emerging dis-
eases. Further, not only does IDSP provide training and
equipment support to the staff, but also ensures contin-
gency funds for outbreak investigations, making it rather
indispensable in disease monitoring at local levels.
The age paranoia
The attack rates observed in our study increased with
age and were highest in the 10–15 years age group. This
re-confirms findings from earlier studies in the region
(57.1% in 5–14 years age) [9]. Ray et al. reported a shift
in the median age of diphtheria in Calcutta, in as
early as 1998 and attributed the shift to good primary
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in 1992 [13] and Andhra Pradesh between 2003–2006
[12]. A recent outbreak in Assam reported over 70% of
the cases between 15- 45 years of age confirming the up-
ward trend for disease incidence in all regions of the
country [20]. Although the size of the outbreak does not
support any statistical claims for the issue, it does serve as
an early warning for the region and should not be ignored.
The reasons for the observed age shift in Dhule are a chal-
lenge to be investigated.
Age shift, is considered an indicator of good under five
immunization [27]. This is however not the case in
Dhule given that the vaccination coverage has been con-
sistently low over years. As per District Level Household
and Facility Survey (DLHS 2007/2008) coverage of DPT3
was 45.2% and the BCG- DPT3 dropout rate stood at
14.6% in the district [28]. It is also prudent to recognize
that the coverage thresholds required for herd protection
to eliminate disease are not necessarily the same as those
that will result in a shift in the age, and could in fact
be lower.
Furthermore, age shift has also been documented before
mass immunizations were instituted and factors such as
migration, nutritional status, displacement, socio-econo-
mic conditions, coexistence of large groups of susceptible
children and adults, and deterioration of health infrastruc-
ture played a role and in fact may offer partial explanation
to our observations given the tribal and predominantly
rural nature of the area [7,29,30].
Another plausible explanation is the improved primary
immunization rates in the last five years post introduc-
tion of the National Rural Health Mission (NRHM). This
may actually have led to susceptible adolescents out-
numbering the number of susceptible children [1]. Joint
WHO-UNICEF and other national and state surveys peg
the coverage between 60–80% between 2005–2009 res-
pectively (Table 2). However, a minimum coverage of
90% in children under five and 75% in adults is neces-
sary to confer herd immunity and current coverage rates
in the district remain rather inadequate [31]. Addition-
ally, why the age shift is limited to adolescents despite
susceptible adults remain unclear.
Despite the awareness of the issue in the region, accu-
rate data on immunization coverage were unavailable.
The routine immunization monitoring system calculatesTable 2 DPT3 coverage estimates for India and Maharashtra s
2004 2005 200
Official Government Estimate (India) 87 90 94
WHO-UNICEF Joint Estimate (India) 64 67 66
DLHS 2 and 3 (Maharashtra) 72 - -
DLHS 2 and 3 (Dhule district) 88 - -
(Source [11,32-34])rates as per targets (number of children vaccinated) pro-
vided by the state and reports over vaccination by 10-
12% [35]. Standardized monitoring mechanisms with
routine data quality and accuracy checks for appropriate
denominators may help improve understanding of ac-
tual coverage.
Other factors that contribute to the low immunization
coverage include lack of awareness, misconceptions, avoi-
ding immunizations for trivial reasons, migration, declin-
ing enthusiasm to routine immunization and unilateral
focus on polio campaigns [2]. Health worker attitude and
skills, vaccine condition, and cold chain influence vaccine
success and regular audits must be made part of monito-
ring and evaluation activities. Supportive supervision of
immunization practices by external consultants and med-
ical colleges has demonstrated significant improvements
in coverage and may be of added value in the district [36].
The booster dilemma
The Universal Immunization Program (UIP) in India of-
fers three doses of DwPT at six, ten and fourteen weeks
and two booster doses at 16–24 months and five years of
age [11]. Over 94-100% children develop protective levels
of antibodies following primary immunization but in the
absence of boosters the titres drop and over 20–65% of
adults may become susceptible [5,30,37,38]. Waning of
antibodies with age has been documented through se-
rological surveys in both developing and developed
countries including India [6,39]. Immunization sche-
dule especially the spacing of boosters play an impor-
tant role in maintaining lifelong immunity [8,40]. DT
boosters throughout adult life at ten year intervals
and minimum two booster doses over 40 years of age
are recommended [41-44].
The need to revise the UIP is urgent and has been
discussed before [16]. Adult boosters at ten year inter-
vals are currently non-existent in the country [45] and
could be considered vis-a-vis the resource availability
and urgency. DT booster at school entry and leaving
should be considered to cover adolescents. Serological
studies for antibody titres in adults and adolescents can
assist in identifying the timing and number of booster
doses for the district [10]. Secondly, data on booster
1 and 2 coverage is not collected routinely [46]; or
reported to the WHO. This calls for moving beyondtate (in%)
6 2007 2008 2009 2010 2011
98 84 97 90 85
71 72 72 72 72
- 79 - - -
- 45 - - -
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booster coverage as an indicator of health system per-
formance under NRHM.
Immunized or not- does it really matter?
We report invasive disease in a child with documented
primary immunization and death in a partially immu-
nized child. Disease despite primary immunization has
been reported earlier from Rajkot, Gujarat [2] and from
Malegaon and Dhule district [9]. The death of the child
despite ADS was due to advanced clinical symptoms at
admission and the fact that the antitoxin only neutralizes
circulating toxin that is not still bound to the tissue [5].
The disease was probably also more severe due to in-
complete immunization [23,24]. Case fatality increases
with late presentation, delay in diagnosis and non-
availability of ADS [35,47]. None of which were true in
our case. Death occurred due to upper airway obstruc-
tion which is the commonest complication in children
due to their small airways [48]. Issues such as vaccine
quality and / or vaccine failure should be investigated
given that cases with previous DPT doses have reported
the disease in the district [16].
Vaccination history was unavailable for a majority of
the cases in our study like in most others [49]. Record-
ing and updating immunization status on birth or school
leaving certificates or the recently issued Aadhaar cards
(Unique Identification Authority of India) that carry
weight throughout adult life may help resolve the issue
Biotype, toxigenicity and sensitivity
Genotyping diphtheria strains not only allows differenti-
ation of endemic, epidemic, and imported strains but
also helps monitor its adaptability, virulence, and patho-
genicity, thus ensuring adequacy of protection through
existing vaccines [50]. Few published studies in India re-
port the biotype or toxigenicity [17,21]. It was not pos-
sible to conduct toxigenicity or strain identification on
the samples in our study due to contamination which is
a serious limitation. Elek facilities were unavailable at
district headquarters and even in the identified referral
lab under IDSP. Laboratory strengthening for endemic
diseases is especially vaccine preventable diseases like
diphtheria currently indispensable.
Frequent isolation of non-toxigenic strains in immu-
nized individuals may offer an explanation to disease in
previously immunized children in our study [51]. In
India, two separate events of non-toxigenic strain isola-
tion have been reported in Pondicherry [17,22]. Non-
toxigenic strains associated with invasive disease have
also been found resistant to cefotaxime and ciprofloxacin
[52]. However, a study from North India reports 83.3% of
the 54 isolates- 90% of which were toxigenic and biotype
var intermedius were resistant to trimethoprim /sulphamethaxazol, 18.5% to ampicillin and one to ciprofloxacin
[21]. The correlation between toxigenicity, biotype and
drug resistance is therefore unclear.
An earlier study from Dhule district reported biotype
gravis as the most common strain (1991–2007) and all
isolates were sensitive to penicillin and erythromycin [9].
However, all three culture positive samples in our study
including the death case were resistant to penicillin,
ampicillin, cefuroxime, and ciprofloxacin which is a sig-
nificant concern particularly in a predominantly rural
area where the disease has probably been long endemic.
In the absence of strain and toxigenicity data it is pre-
mature to comment on the resistance to drugs found in
our study. Nonetheless, the seriousness of the issue
cannot be undermined and emerging resistance, if
any, should be closely monitored and clinicians regu-
larly updated.
Clinical management and patient outcomes
We report ten smear and three culture positives and one
case of smear negative and culture positive probably be-
cause of poor sample collection techniques [18]. Over
50% of the culture negative cases had been administered
antibiotics before sample collection which calls for re-
fresher training and developing job aids for sample col-
lection and processing particularly at the field level.
Despite the shift in median age, clinical features re-
main largely similar to those observed in the pre-vaccine
era [6,18] unlike cases in the Eastern Europe epidemic
where only 32.5% of the cases presented with a classical
membrane [8,53]. Seven cases (64%) in our study pre-
sented with a well formed membrane and four (36%)
with a tonsillar patch. Physicians, both public and pri-
vate should be sensitized to maintain a high index of
suspicion for diphtheria even in the absence of classical
symptoms and regular reminders through Continuing
Medical Education (CME) sessions should be organized
as a reminder of disease endemicity.
All ten cases in our study recovered completely and
were asymptomatic on discharge. In 2005, seven deaths
(CFR 10%) were reported from Dhule and Malegaon dis-
tricts due to the non-availability of ADS [9,54]. A CFR
of nine per cent in our study despite availability of ADS
is unacceptable although we do report difficulty in ob-
taining ADS at short notice. Vaccination at discharge
was not possible due to unavailability of the DT vaccine.
Maintaining contingency funds for local purchases and
pre-agreements with local vendors to obtain ADS and
DT vaccines at short notice during outbreaks should be
considered in district preparedness plans.
The duration of antibiotic therapy ranged from seven
to ten days in cases and three to five days in contacts in
our study which should be revised to the current guide-
lines of 14 days treatment to both. Repeat swab for
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importantly, standard case management protocols need
to be developed for diphtheria and regularly updated
based on drug sensitivity testing for the district.
Surveillance is the key
Absence of mandatory case based reporting, weak labo-
ratory networks, tendency of peripheral staff to under/
non report cases due to fear of action from superiors
and weak data analysis at the district level failed to pro-
vide a real picture of the disease burden in Dhule district
in the past. Despite regular sporadic incidence of disease,
institutional learning has been poor.
The outbreak successfully demonstrated the strengths
of IDSP in early detection and reporting of emerging
diseases. Given that the outbreak was localized, large
and geographically within the district it was successful in
drawing attention. Effective control and prompt res-
ponse helped cap the fatality rate. Routine surveillance
has now improved through regular supervision by the
district surveillance unit and although under- reporting
still exists, review of data and its quality is improving
steadily. The outbreak validates the fact that surveillance
is indispensable in furthering our understanding of
changes in both the organism and its victims and this
should be strongly advocated at all levels.
Limitations of the study
We report data for one particular outbreak especially
when diphtheria is endemic in the district with sporadic
cases reported for several years. Immunization history
and vaccination cards were unavailable in majority of
cases despite attempts made to recover them. Parental
recall was also poor. Strain identification and toxigeni-
city testing was not possible due to sample contamina-
tion. Although the use of retrospective secondary data
and especially from an outbreak of this size does not
allow generalizations to other areas or populations, there
are some issues that could be common and help discre-
tionary collateral learning. Better documentation of the
onset, progress and control of outbreaks in the district is
necessary to allow institutional learning.
Conclusion
The outbreak confirms the upward trend in median age
of diphtheria incidence observed in other states of India.
Reasons for the shift only to adolescents despite consis-
tent poor immunization coverage and a sufficient pool
of susceptible adults - remain unclear. Vaccination pro-
grams in the district need to be assessed for efficiency
and stepped up to prevent future outbreaks. Concomi-
tant efforts should focus on improving and monitoring
primary immunization and booster coverages across all
age groups. Gradual introduction of adolescent and adultimmunization at ten year intervals may become neces-
sary as the next step to a long term futuristic strategy.
Laboratory networks for genotyping and toxigenicity
testing at district headquarters requires strengthening.
Contingency funds and pre- agreements with local ven-
dors to obtain ADS and DT/Td vaccines at short notice
during outbreaks and standard case management proto-
cols will improve patient outcomes and arrest case fatal-
ity rates. Monitoring disease trends, clinical progression,
emerging strains and mutations, alongside drug resis-
tance through robust and effective surveillance is the
pragmatic way forward.
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